{"lastClose": 1.2000000476837158, "len": 475, "date": "2023-02-06", "alpha_1": -0.9195148404983788, "beta_1": 0.20093609638080182, "drawup_1": 0.7325581218050006, "natr_1": 30.36486917115863, "sup_1": -0.024722283758496496, "res_1": 0.30805543496653376, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 62.19008361150882, "adx_1": 21.29258136778585, "drawdown_1": -0.9065934078890032, "stratHoldSharpe_1": -1.8051271733383627, "stratHoldAlpha_1": 249.74322695477886, "stratHoldDrawdown_1": -0.8185426090280415, "alpha_3mo": -0.7441430978563256, "beta_3mo": -0.6614060599290935, "drawup_3mo": 0.4117647223819081, "natr_3mo": 30.36486917115863, "sup_3mo": -0.04972232515060922, "res_3mo": 0.025555424204584388, "bullPattern_3mo": [], "bearPattern_3mo": ["BELTHOLD", "COUNTERATTACK"], "rsi_3mo": 75.47528747621622, "adx_3mo": 51.709177294788425, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": 0.81570434800087, "stratHoldAlpha_3mo": 251.5642926166693, "stratHoldDrawdown_3mo": -0.3969675966724687, "Name": "LumiraDx Limited", "Sector": "Health Care", "Market Cap": 300712580, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Country": "Cayman Islands", "alpha%_1": 0.004315715330706233, "beta%_1": 0.06431029939691443, "drawup%_1": 0.6939300837210762, "natr%_1": 1.0, "drawdown%_1": 0.004804021023586294, "stratHoldSharpe%_1": 0.0022641445825878604, "stratHoldAlpha%_1": 1.1826455015477191e-07, "stratHoldDrawdown%_1": 0.005906078187294829, "alpha%_3mo": 0.06951316704726843, "beta%_3mo": 0.004333201659370351, "drawup%_3mo": 0.7698710468268943, "natr%_3mo": 1.0, "drawdown%_3mo": 0.001530643214094369, "stratHoldSharpe%_3mo": 0.3084951906509623, "stratHoldAlpha%_3mo": 0.5040966708312727, "stratHoldDrawdown%_3mo": 0.0013124090610018133}